Thomas Mohr

20PUBLICATIONS
150CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsPredictive and prognostic markersMedical biochemistry - inorganic elements and compoundsFluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 28, 2026
RiboScreenTM Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease †.

|Jun 02, 2026
EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer.

|Nov 24, 2025
Rroid2 regulates effector-to-memory CD8+ T cell differentiation during infection in vivo.

Julia Erber, Carmen Stecher, Valerie Plajer

|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|May 06, 2025
EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer.

Dana Krauß, Veronica Moreno-Viedma, Emi Adachi-Fernandez

|Aug 29, 2024
Candidate Signature miRNAs from Secreted miRNAome of Human Lung Microvascular Endothelial Cells in Response to Different Oxygen Conditions: A Pilot Study.

Wolfgang Schaubmayr, Matthias Hackl, Marianne Pultar

Pageof 4

Frequent Collaborators

5 joint publications

Walter Berger

4 joint publications

Christopher Gerner

3 joint publications

Michael Grusch

3 joint publications

Maria Sibilia